The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants
- PMID: 1776437
The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants
Abstract
To study the influence of hypoallergenic milk on the occurrence of allergic diseases, thirty-three high risk, normal full-term newborns were divided into two groups with comparable family allergy score (FAS) and cord serum IgE. Group A consisted of 18 babies fed since birth with regular formula, while group B included 15 babies fed breast milk and/or NAN H.A. (Hypoallergenic infant formula) for the first 6 months of life. Close clinical observations for the appearance of atopic dermatitis, allergic rhinitis and wheezing as well as serial examination of total serum IgE and milk-specific IgE antibodies were done during the first year of life. The results showed: 1) Infants fed regular formula had a higher incidence of moderate to severe atopic dermatitis (AD) and allergic rhinitis (AR) than those fed NAN H.A. (39% vs 13% for AD; and 33% vs 13% for AR), but the difference was not significant. There was no difference in the incidence of wheezing between these two groups; 2) There was no relationship between cord blood IgE and FAS; 3) Neither the cord blood IgE nor FAS influenced the occurrence of allergic diseases and total serum IgE at one year of age; 4) Hypoallergenic milk (NAN H.A.) could support normal growth and development. In conclusion, a higher incidence of moderate to severe AD and AR was found in high risk infants fed regular formula than in those fed hypoallergenic milk. However, a study with a larger number of babies and a longer period of follow-up is needed to obtain a solid conclusion.
Similar articles
-
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review.
-
Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow-up.Acta Paediatr Suppl. 1996 May;414:1-21. doi: 10.1111/j.1651-2227.1996.tb14267.x. Acta Paediatr Suppl. 1996. PMID: 8831855 Clinical Trial.
-
Nutrition, growth, and allergic diseases among very preterm infants after hospital discharge.Dan Med J. 2013 Feb;60(2):B4588. Dan Med J. 2013. PMID: 23461996 Review.
-
[Early feeding in infancy and atopic dermatitis - a prospective observational study].Klin Padiatr. 2009 Mar-Apr;221(2):78-82. doi: 10.1055/s-2007-993204. Epub 2008 Feb 12. Klin Padiatr. 2009. PMID: 18270883 German.
-
[The prevention of allergic diseases with a hypoallergenic formula: a follow-up at 24 months. The preliminary results].Pediatr Med Chir. 1994 May-Jun;16(3):251-4. Pediatr Med Chir. 1994. PMID: 7971447 Italian.
Cited by
-
Philippine guidelines on the dietary primary prevention of allergic diseases in children.Asia Pac Allergy. 2024 Dec;14(4):191-213. doi: 10.5415/apallergy.0000000000000158. Epub 2024 Sep 26. Asia Pac Allergy. 2024. PMID: 39624442 Free PMC article. Review.
-
A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated meta-analysis.World Allergy Organ J. 2017 Jul 26;10(1):27. doi: 10.1186/s40413-017-0158-z. eCollection 2017. World Allergy Organ J. 2017. PMID: 28781718 Free PMC article. Review.
-
WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.Cochrane Database Syst Rev. 2017 May 25;5(5):CD003664. doi: 10.1002/14651858.CD003664.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Oct 19;10:CD003664. doi: 10.1002/14651858.CD003664.pub6. PMID: 28542713 Free PMC article. Updated.
-
Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis.EFSA J. 2021 Jun 16;19(6):e06603. doi: 10.2903/j.efsa.2021.6603. eCollection 2021 Jun. EFSA J. 2021. PMID: 34140987 Free PMC article.
-
Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis.BMJ. 2016 Mar 8;352:i974. doi: 10.1136/bmj.i974. BMJ. 2016. PMID: 26956579 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous